Controls | CDI patients | p-value | |||
---|---|---|---|---|---|
No. | % | No. | % | ||
Previous health care exposure | 53/61 | 87 | 64/66 | 97 | 0,152 |
• Acute hospital | 52/53 | 98 | 62/64 | 97 | |
• Nursing home | 1/53 | 2 | 1/64 | 1,5 | |
• LTCFa | 0/53 | 0 | 1/64 | 1,5 | |
Any antibiotic use during 1 month preceding symptom onset | 33/52 | 63 | 58/66 | 88 | 0,001* |
• Clindamycin | 1/49 | 2 | 2/84 | 2,3 | |
• Fluoroquinolones | 7/49 | 14 | 13/84 | 15,4 | |
• Amoxicillin–clavulanic acid | 22/49 | 45 | 36/84 | 43 | |
• Otherb | 19/49 | 39 | 33/84 | 39 | |
Antacids use at admission | 39/55 | 71 | 48/57 | 84 | 0,138 |
• Histamine 2-blocker | 5/39 | 13 | 3/48 | 6 | |
• Proton-pump inhibitor (PPI) | 34/39 | 87 | 45/48 | 94 | |
Number of narcotics at admission | 47/53 | 89 | 48/58 | 83 | 0,832 |
• 1 narcotic | 21/47 | 45 | 17/48 | 35 | |
• 2 narcotics | 15/47 | 32 | 16/48 | 33 | |
• 3 narcotics | 7/47 | 15 | 11/48 | 23 | |
• 4 narcotics | 3/47 | 6 | 3/48 | 6 | |
• 5 narcotics | 1/47 | 2 | 1/48 | 2 | |
Diabetes mellitus | 14/57 | 25 | 11/64 | 17 | 0,317 |